Informations générales
Intitulé de l'offre : M/W Post Doctoral Researcher specialized in bio informatics (H/F)
Référence : UMR5239-ISASER-027
Nombre de Postes : 1
Lieu de travail : LYON 07
Date de publication : lundi 20 novembre 2023
Type de contrat : CDD Scientifique
Durée du contrat : 24 mois
Date d'embauche prévue : 1 février 2024
Quotité de travail : Temps complet
Rémunération : From 2 934€ gross per month depending on experience
Niveau d'études souhaité : Niveau 8 - (Doctorat)
Expérience souhaitée : Indifférent
Section(s) CN : Molecular and structural biology, biochemistry
Missions
Investigate the B. Fragilis Type 6 Secretion System using integrative structural determination and protein design approaches.
Activités
Integration of cross-linking mass-spectrometry data, cryoEM, and AlphaFold2 structures to construct comprehensive models of the B. Fragilis T6SS membrane complex.
Designing peptidic T6SS inhibitors to regulate the assembly and modulate the secretion activity.
Compétences
The ideal candidate should have a background primarily in biophysics of macromolecules or bioinformatics, with knowledge in one or more of the following domains: statistics, computer science, statistical mechanics, chemistry, molecular biology, or cell biology. Proficiency in molecular dynamics and/or machine learning is highly valued. Strong programming skills in Python are essential, as well as experience working on UNIX systems and computer clusters. Fluency in both spoken and written English is required. The ability to work effectively in a team and collaborate with experimentalists is also a necessity.
Contexte de travail
The research will be conducted at the Laboratoire de Biologie et Modélisation de la Cellule (LBMC), a research institute situated on the campus of the Ecole Normale Supérieure (ENS) in Lyon. The postdoctoral position will be part of the Dynamics and Control of Biological Assemblies and Macromolecular Machines team, within the framework of the ANR Cameleon project. The project will be supervised by Riccardo Pellarin, Paulo Telles de Souza, and Juliette Martin, and will involve collaboration with teams led by Eric Durand (IMM Marseille), Eduardo Rocha (Institut Pasteur Paris), Florian Stengel (University of Konstanz), and Ben Ross (Dartmouth School of Medicine).